GA
TMO icon

Geneva Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Geneva Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.39M Sell
7,951
-621
-7% -$104K 0.02% 297
2017
Q1 		$1.32M Sell
8,572
-719
-8% -$110K 0.02% 297
2016
Q4 		$1.31M Sell
9,291
-1,244
-12% -$183K 0.03% 275
2016
Q3 		$1.68M Sell
10,535
-367
-3% -$56.6K 0.03% 226
2016
Q2 		$1.61M Sell
10,902
-11
-0.1% -$1.62K 0.03% 225
2016
Q1 		$1.54M Sell
10,913
-20
-0.2% -$2.68K 0.03% 225
2015
Q4 		$1.55M Buy
10,933
+5,447
+99% +$727K 0.03% 234
2015
Q3 		$671K Buy
5,486
+3,759
+218% +$490K 0.01% 345
2015
Q2 		$224K Buy
+1,727
New +$225K ﹤0.01% 582
2014
Q4 		– Sell
-2,306
Closed -$281K – 739
2014
Q3 		$281K Sell
2,306
-73
-3% -$8.88K 0.01% 528
2014
Q2 		$281K Sell
2,379
-200
-8% -$23.5K 0.01% 530
2014
Q1 		$310K Buy
+2,579
New +$307K 0.01% 471
2013
Q4 		– Sell
-10,085
Closed -$929K – 592
2013
Q3 		$929K Buy
10,085
+2,285
+29% +$207K 0.02% 262
2013
Q2 		$660K Buy
+7,800
New +$649K 0.02% 259

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geneva Advisors's TMO Position: Q2 2017 in Review

Geneva Advisors reduced its Thermo Fisher Scientific (TMO) stake by 7.2% in Q2 2017, selling an estimated $104K and leaving 7,951 shares worth $1.39M. The position accounts for 0.02% of the portfolio, ranked #297.

Geneva Advisors first reported a position in TMO in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.68M in Q3 2016. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2017.

  • Geneva Advisors held 7,951 shares of Thermo Fisher Scientific worth $1.39M as of Q2 2017.
  • Geneva Advisors sold 621 Thermo Fisher Scientific shares in Q2 2017, an estimated $104K.
  • Thermo Fisher Scientific made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #297 holding.
  • Geneva Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 14 quarters since.
  • Geneva Advisors's Thermo Fisher Scientific position peaked at $1.68M in Q3 2016.
  • 1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.